Good morning - I hope you're feeling refreshed after the long weekend!
The Agenda is complete.
12pm: wrapping it up there. It was a rather strange collection of announcements, as might be expected on the first day back after a Bank Holiday. We should get a more normal set of updates tomorrow! Cheers.
Companies Reporting
Name (Mkt Cap) | RNS | Summary | Our view (Author) |
---|---|---|---|
Bodycote (LON:BOY) (£940m) | SP +4% For the recent 4-month period, “core” revenues are down 5% organically. Total revenues down 6%. “Supply chains improving in Civil Aerospace; conditions remain weak in Automotive and Industrial markets.” Full year outlook in line with an H2 profit weighting. No material direct exposure to tariffs. Net debt £90m. | AMBER (Graham) [no section below] This issued a profit warning last month, prompting me to downgrade my stance to neutral. Today’s update reassures that the outlook has not deteriorated any further, with the share price reaction suggesting investor relief. The company’s ongoing “Optimise” programme targets savings and benefits of £12-14m p.a., and the company is exploring the potential to expand this. At a modest earnings multiple (and a neutral StockRank) I remain comfortable with my neutral stance. This is a reputable company with a strong heritage but in the short-term I would be a little cautious around the potential for another profit warning - especially given the expected H2 weighting for adjusted profits. | |
Elementis (LON:ELM) (£770m) | Enterprise value of sale $121m, net cash proceeds c. $55m. $50m buyback. Outlook unchanged. Disposal is expected to improve adj op margin by +2.4%. | AMBER (Roland) [no section below] The Talc business has been sold after a difficult year for a multiple of 15x 2024 operating profit. The new CEO will now try to improve the performance of the remainder of the business. This could be an interesting turnaround, but revenue has only risen by an average of 1% per year over the last decade and profitability has been variable. Further research would be needed for me to form a view on this situation, although perhaps Elementis will benefit from a wider chemical sector recovery. For now, I will give the new and highly-experienced CEO the benefit of the doubt and upgrade our view to neutral. | |
Enquest (LON:ENQ) (£212m) | Production efficiency >90%. Q1 production 42k boepd. Net debt $405m.… |